Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. User Boards ›
  4. NASDAQ OMX GlobeNewswire Message Board

Metabolomics Market by Product & Application - 202

Message Board Public Reply | Private Reply | Keep | Replies (0)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 301275
(Total Views: 30)
Posted On: 11/16/2017 1:00:34 AM
Avatar
Posted By: News Desk 2018
Metabolomics Market by Product & Application - 2025

LAS VEGAS, Nov. 16, 2017 (GLOBE NEWSWIRE) -- Global Metabolomics Market is identification and quantification of the complete set of metabolites in a biological system. Metabolomics are used in wide range of applications such as drug testing, toxicological studies, and detection of diseases such as Alzheimer’s and necrosis by using biomarkers. Biomarkers are traceable substances that are inserted into an organism either for disease diagnostic or to examine health parameters. Metabolomics can also help in diagnosis of different subtypes of Alzheimer’s disease for permitting more controlled therapies. The biomarkers can be used for diagnosis and prognosis of malignant tumors. Metabolomics is also used to improve the detection of various cancers such as kidney, prostate, liver, and pancreas.

High performance liquid chromatography (HPLC) segment occupied the largest share of metabolomics market in 2016 and is expected to maintain its dominance during forecast period. This can be attributed to number of factors such as high speed and accuracy of technique. Biomarker discovery segment occupied the largest share of the overall market in 2016, due to factors such as enhancement in effectiveness and reliability of metabolic profiling of biomarkers for drug discovery and diagnosing malfunction metabolites.

Get Sample of this report: http://www.crystalmarketresearch.com/report-sample/HC0635

U.S. accounted for the major share of the North American metabolomics market in 2016, owing to factors such as easy availability of technologically advanced products, rise in adoption rate of personalized medicines, and highly developed healthcare infrastructure. Emerging markets such as China and India will exhibit favorable growth during the forecast period with rising emphasis on biopharmaceutical research and development activities in these countries.

Market Players:

  • LECO Corporation
  • Agilent Technologies Inc.
  • Waters Corporation
  • Bio-Rad Laboratories Inc.
  • Thermo Fisher Scientific Inc.
  • Shimadzu Corporation
  • Human Metabolome Technologies Inc.
  • Metabolon Inc.
  • Bruker Corporation.

Product development is the key strategy adopted by the major players operating in the global market to expand and strengthen their product portfolio and increase their market share. For instance, in May 2016, Agilent Technologies Inc. introduced The Agilent 5110 ICP-OES to its lineup of inductively coupled plasma-optical emission spectrometers. This new system will facilitate more accurate ICP-OES analysis. Likewise, in November 2016, Metabolon, Inc. launched the Meta IMD test that speeds up the diagnosis of inherent metabolic disorders.

Buy Report: http://www.crystalmarketresearch.com/checkout/HC0635

Key Findings of the Research Study:

  • HPLC segment held the largest share of the global metabolomics market in 2016, owing to accuracy and reliability of the technique.
  • Biomarker discovery segment held the major share of the metabolomics market in 2016, owing to the high efficiency of metabolic biomarkers for managing diseases at the metabolic level.
  • North America held around two-fifth of the global share of the overall market in 2016, due to rise in adoption rate of personalized medicines and easy access to technologically advanced products.
  • Asia-Pacific market is projected to grow with the highest CAGR over the forecast period as a result of rise in age related disorders and prevalence of high unmet medical needs.

About Crystal Market Research

Crystal Market Research is a U.S. based market research and business intelligence company. Crystal offers one stop solution for market research, business intelligence, and consulting services to help clients make more informed decisions. It provides both syndicated as well as customized research studies for its customers spread across the globe. The company offers market intelligence reports across a broad range of industries including healthcare, chemicals & materials, technology, automotive, and energy.

Contact: 304 South Jones Blvd, Suite 1896, Las Vegas NV 89107, United States Toll Free: + 1-888-213-4282 Email: sales@crystalmarketresearch.com Website: http://www.crystalmarketresearch.com



(0)
(0)








Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us